54 results
8-K
EX-4.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below … be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value
8-K
EX-4.3
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Preferred Investment Option on the date … of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Preferred Investment Option, that is being
8-K
EX-4.2
ycoiqhetwp8
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.1
o91ksfos7f5e55xrn
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.2
mgldgnrwlbw
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.3
u9sqw6pnstghcpzh0t
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.3
tyhnutytq5ayz40x19
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.2
q2e1xdpi
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.1
xjnwu4k
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
424B3
y4l13fgvck6s ul0yi1
6 Jul 22
Prospectus supplement
2:43pm